|
SERINC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.22128998422977E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.79836179070981E-12 |
| Normal-vs-Stage2 |
1.270699999667E-07 |
| Normal-vs-Stage3 |
1.433850E-02 |
| Normal-vs-Stage4 |
3.340000E-02 |
| Stage1-vs-Stage2 |
5.144600E-01 |
| Stage1-vs-Stage3 |
9.781800E-02 |
| Stage1-vs-Stage4 |
5.940000E-01 |
| Stage2-vs-Stage3 |
2.574800E-01 |
| Stage2-vs-Stage4 |
8.031200E-01 |
| Stage3-vs-Stage4 |
6.209400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.29970478823793E-11 |
| Normal-vs-AfricanAmerican |
2.44099999990866E-07 |
| Normal-vs-Asian |
1.180790E-01 |
| Caucasian-vs-AfricanAmerican |
7.023000E-01 |
| Caucasian-vs-Asian |
5.613800E-01 |
| AfricanAmerican-vs-Asian |
4.638800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.20723439525727E-12 |
| Normal-vs-Female |
2.17509999999033E-05 |
| Male-vs-Female |
8.740100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.23859999995513E-06 |
| Normal-vs-Extreme_Weight |
3.21620508003662E-12 |
| Normal-vs-Obese |
4.06350000000666E-05 |
| Normal-vs-Extreme_Obese |
1.017930E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.865400E-01 |
| Normal_Weight-vs-Obese |
3.421800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.780200E-01 |
| Extreme_Weight-vs-Obese |
2.031700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.481000E-01 |
| Obese-vs-Extreme_Obese |
4.690800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.098300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.23490004070248E-09 |
| Normal-vs-Age(61-80Yrs) |
8.80007178238884E-12 |
| Normal-vs-Age(81-100Yrs) |
9.821000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.813200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.203600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.890800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.736990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.226000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.894400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.5269565046292E-12 |
| Normal-VS-Type2 PRCC |
4.45800000000718E-05 |
| Normal-VS-KIRP CIMP |
1.370430E-01 |
| Normal-VS-Unclassified PRCC |
2.35709999996114E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.465000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.846770E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.832600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.712000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.577600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.920960E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.59709961606347E-10 |
| Normal-vs-N1 |
3.953800E-02 |
| Normal-vs-N2 |
3.11959999999001E-06 |
| N0-vs-N1 |
3.328400E-02 |
| N0-vs-N2 |
5.320800E-01 |
| N1-vs-N2 |
1.669800E-01 |
|
|
